By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Investing > Tarsus Pharmaceuticals Shares Fall 11% After Public Offering News
Investing

Tarsus Pharmaceuticals Shares Fall 11% After Public Offering News

News Room
Last updated: 2024/03/01 at 8:06 PM
By News Room
Share
1 Min Read
SHARE

By Stephen Nakrosis


Shares of Tarsus Pharmaceuticals were trading in the red in Thursday’s after-hours session, following news the company commenced an underwritten public offering for $100 million of its common stock and warrants.

After the bell, Tarsus shares had fallen 11% to trade at $34.01. Shares closed the day’s regular session at $38.22, rising less than 1%.

Tarsus has a market cap of $1.3 billion, 34.22 million shares outstanding and a public float of 25.49 million shares.


Write to Stephen Nakrosis at stephen.nakrosis@wsj.com


Read the full article here

News Room March 1, 2024 March 1, 2024
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Why SCHD Deserves The Benefit Of The Doubt (NYSEARCA:SCHD)

This article was written byFollowA financial researcher and avid investor with a…

Japan business accuses Tokyo of ‘mistake’ in US trade talks strategy

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

Iran’s foreign minister: Israel’s war sabotaged diplomacy. The US can revive it

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

Wall Street turns more bullish on US stocks despite Donald Trump’s tariff threats

Stay informed with free updatesSimply sign up to the US equities myFT…

Save the Children suspends BCG partnership over Gaza work

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Why Home Builders Are Bouncing Today—and Why Their Stocks Are Good Buys

By News Room
Investing

This Beaten-Down Industrial Stock Wants to Call America Home. Why It’s Time to Buy.

By News Room
Investing

These 8 Dividend Aristocrats Can Protect Your Portfolio in a Downturn

By News Room
Investing

Some Lenders Benefit From SBA’s Troubled Loan Program

By News Room
Investing

Social Security Is in Turmoil. Should You Lock In Benefits Now?

By News Room
Investing

Hims & Hers Stock Is Due for a Crash Diet. The GLP-1 Surge Is Fading Fast.

By News Room
Investing

Opinion: The stock-market selloff isn’t over yet. Here are 4 reasons why.

By News Room
Investing

With Trump’s tariffs paused, ‘Big Three’ automakers may race to build inventories

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?